11月6日 - ** 疫苗生产商NovavaxNVAX.O的股价在早盘交易中上涨1.4%，至7.79美元。
** 该公司现在预计 (link) 2025 年调整后的营收将在 10.4 亿美元至 10.6 亿美元之间，而此前的预期范围为 10 亿美元至 10.5 亿美元。
** 截至 9 月 30 日的季度净亏损从去年同期的 1.21 亿美元扩大到 2.02 亿美元。
** 公司季度收入 700 亿美元，超出分析师平均预期的 4213 万美元 - LSEG 数据
** 包括本交易日的走势在内，该股今年累计下跌约 4
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.